BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 33106352)

  • 1. Ferroptosis Mediates Cuprizone-Induced Loss of Oligodendrocytes and Demyelination.
    Jhelum P; Santos-Nogueira E; Teo W; Haumont A; Lenoël I; Stys PK; David S
    J Neurosci; 2020 Nov; 40(48):9327-9341. PubMed ID: 33106352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of Iron Metabolism and Short-Term Cuprizone Treatment of C57BL/6 Mice.
    Pandur E; Pap R; Varga E; Jánosa G; Komoly S; Fórizs J; Sipos K
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
    Taylor LC; Gilmore W; Ting JP; Matsushima GK
    J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.
    Acs P; Selak MA; Komoly S; Kalman B
    J Neuroimmunol; 2013 Sep; 262(1-2):128-31. PubMed ID: 23890807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.
    Liu L; Belkadi A; Darnall L; Hu T; Drescher C; Cotleur AC; Padovani-Claudio D; He T; Choi K; Lane TE; Miller RH; Ransohoff RM
    Nat Neurosci; 2010 Mar; 13(3):319-26. PubMed ID: 20154684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
    Tomas-Roig J; Wirths O; Salinas-Riester G; Havemann-Reinecke U
    CNS Neurosci Ther; 2016 May; 22(5):387-95. PubMed ID: 26842941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional differences between grey and white matter in cuprizone induced demyelination.
    Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
    Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
    Skripuletz T; Gudi V; Hackstette D; Stangel M
    Histol Histopathol; 2011 Dec; 26(12):1585-97. PubMed ID: 21972097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
    Acs P; Komoly S
    Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
    Steelman AJ; Thompson JP; Li J
    Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
    Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
    J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CZ-7, a new derivative of Claulansine F, promotes remyelination induced by cuprizone by enhancing myelin debris clearance.
    Wang SS; Bi HZ; Chu SF; Dong YX; He WB; Tian YJ; Zang YD; Zhang DM; Zhang Z; Chen NH
    Brain Res Bull; 2020 Jun; 159():67-78. PubMed ID: 32289743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
    Tanaka T; Murakami K; Bando Y; Yoshida S
    J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage.
    Liu J; Tian D; Murugan M; Eyo UB; Dreyfus CF; Wang W; Wu LJ
    J Neurochem; 2015 Oct; 135(2):347-56. PubMed ID: 26173779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuprizone Intoxication Induces Cell Intrinsic Alterations in Oligodendrocyte Metabolism Independent of Copper Chelation.
    Taraboletti A; Walker T; Avila R; Huang H; Caporoso J; Manandhar E; Leeper TC; Modarelli DA; Medicetty S; Shriver LP
    Biochemistry; 2017 Mar; 56(10):1518-1528. PubMed ID: 28186720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR Signaling Regulates Metabolic Function in Oligodendrocyte Precursor Cells and Promotes Efficient Brain Remyelination in the Cuprizone Model.
    Jeffries MA; McLane LE; Khandker L; Mather ML; Evangelou AV; Kantak D; Bourne JN; Macklin WB; Wood TL
    J Neurosci; 2021 Oct; 41(40):8321-8337. PubMed ID: 34417330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.
    Martin NA; Molnar V; Szilagyi GT; Elkjaer ML; Nawrocki A; Okarmus J; Wlodarczyk A; Thygesen EK; Palkovits M; Gallyas F; Larsen MR; Lassmann H; Benedikz E; Owens T; Svenningsen AF; Illes Z
    Front Immunol; 2018; 9():490. PubMed ID: 29593734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model.
    Iocca HA; Plant SR; Wang Y; Runkel L; O'Connor BP; Lundsmith ET; Hahm K; van Deventer HW; Burkly LC; Ting JP
    J Neuroimmunol; 2008 Feb; 194(1-2):97-106. PubMed ID: 18207576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.